These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8195716)

  • 21. 15-Lipoxygenase induction as an index of oxidative stress and atherogenesis.
    Bailey JM; Makheja AN; Simon T
    Biochem Soc Trans; 1993 Nov; 21(4):406S. PubMed ID: 8131980
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitory effect of flavonoids on low-density lipoprotein peroxidation catalyzed by mammalian 15-lipoxygenase.
    da Silva EL; Abdalla DS; Terao J
    IUBMB Life; 2000 Apr; 49(4):289-95. PubMed ID: 10995031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of vascular 15-lipoxygenase induction to atherosclerotic plaque formation in rabbits.
    Simon TC; Makheja AN; Bailey JM
    Prostaglandins Leukot Essent Fatty Acids; 1990 Dec; 41(4):273-8. PubMed ID: 2077542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.
    Gniwotta C; Morrow JD; Roberts LJ; Kühn H
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3236-41. PubMed ID: 9409317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of lipoxygenase-isoforms in atherogenesis.
    Kühn H; Römisch I; Belkner J
    Mol Nutr Food Res; 2005 Nov; 49(11):1014-29. PubMed ID: 16270276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties.
    Sendobry SM; Cornicelli JA; Welch K; Bocan T; Tait B; Trivedi BK; Colbry N; Dyer RD; Feinmark SJ; Daugherty A
    Br J Pharmacol; 1997 Apr; 120(7):1199-206. PubMed ID: 9105693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions.
    Heydeck D; Upston JM; Viita H; Ylä-Herttuala S; Stocker R
    J Lipid Res; 2001 Jul; 42(7):1082-8. PubMed ID: 11441135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of cholesterol oxidation products on the disruption of lipid metabolism and atherosclerotic damage of the aorta in rabbits].
    Vikhert AM; Lankin VZ; Tikhaze AK; Rozinova VN; Nekrasov AS
    Arkh Patol; 1988; 50(11):15-22. PubMed ID: 3233067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Parthasarathy S; Barnes S; Kirk M; Kalyanaraman B; Freeman BA
    Arch Biochem Biophys; 1995 Dec; 324(1):15-25. PubMed ID: 7503550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidation of human low-density lipoprotein by soybean 15-lipoxygenase in combination with copper (II) or met-myoglobin.
    O'Leary VJ; Graham A; Stone D; Darley-Usmar VM
    Free Radic Biol Med; 1996; 20(4):525-32. PubMed ID: 8904293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure elucidation of oxygenated lipids in human atherosclerotic lesions.
    Kühn H; Belkner J; Wiesner R; Schewe T; Lankin VZ; Tikhaze AK
    Eicosanoids; 1992; 5(1):17-22. PubMed ID: 1419075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.
    Cyrus T; Witztum JL; Rader DJ; Tangirala R; Fazio S; Linton MF; Funk CD
    J Clin Invest; 1999 Jun; 103(11):1597-604. PubMed ID: 10359569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidation, lipoxygenase, and atherogenesis.
    Sigal E; Laughton CW; Mulkins MA
    Ann N Y Acad Sci; 1994 Apr; 714():211-24. PubMed ID: 8017770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities.
    Kühn H; Belkner J; Suzuki H; Yamamoto S
    J Lipid Res; 1994 Oct; 35(10):1749-59. PubMed ID: 7852852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of low density lipoprotein and plasma by 15-lipoxygenase and free radicals.
    Yamashita H; Nakamura A; Noguchi N; Niki E; Kühn H
    FEBS Lett; 1999 Feb; 445(2-3):287-90. PubMed ID: 10094474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient experimental anemia in cholesterol-fed rabbits induces systemic overexpression of the reticulocyte-type 15-lipoxygenase and protects from aortic lipid deposition.
    Trebus F; Heydeck D; Schimke I; Gerth C; Kühn H
    Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):419-28. PubMed ID: 12468263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoxygenase treatment render low-density lipoprotein susceptible to Cu2+-catalysed oxidation.
    Lass A; Belkner J; Esterbauer H; Kühn H
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):577-85. PubMed ID: 8670073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15-Lipoxygenase expression in smooth muscle cells from atherosclerotic rabbit aortas.
    Hugou I; Blin P; Henri J; Daret D; Larrue J
    Atherosclerosis; 1995 Mar; 113(2):189-95. PubMed ID: 7605358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice.
    George J; Afek A; Shaish A; Levkovitz H; Bloom N; Cyrus T; Zhao L; Funk CD; Sigal E; Harats D
    Circulation; 2001 Oct; 104(14):1646-50. PubMed ID: 11581143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.